Gary Taylor

Stock Analyst at TD Cowen

(2.57)
# 2,196
Out of 5,150 analysts
148
Total ratings
51.52%
Success rate
0.52%
Average return

Stocks Rated by Gary Taylor

Acadia Healthcare Company
Aug 7, 2025
Maintains: Buy
Price Target: $44$25
Current: $24.07
Upside: +3.86%
Bath & Body Works
Nov 26, 2024
Maintains: Buy
Price Target: $40$42
Current: $23.01
Upside: +82.53%
P3 Health Partners
Nov 20, 2024
Maintains: Hold
Price Target: $45$13
Current: $2.40
Upside: +420.83%
agilon health
Nov 11, 2024
Maintains: Hold
Price Target: $6$2
Current: $0.70
Upside: +186.33%
Humana
Nov 4, 2024
Maintains: Hold
Price Target: $261$268
Current: $183.11
Upside: +46.36%
Alignment Healthcare
Oct 31, 2024
Maintains: Buy
Price Target: $10$13
Current: $18.88
Upside: -31.14%
HCA Healthcare
Oct 28, 2024
Maintains: Buy
Price Target: $450$440
Current: $544.41
Upside: -19.18%
UnitedHealth Group
Oct 18, 2024
Maintains: Buy
Price Target: $601$609
Current: $291.96
Upside: +108.59%
Centene
Jul 31, 2024
Maintains: Buy
Price Target: $80$89
Current: $44.99
Upside: +97.82%
Molina Healthcare
Jul 29, 2024
Maintains: Buy
Price Target: $351$378
Current: $150.04
Upside: +151.93%
Maintains: Hold
Price Target: $183$220
Current: $202.31
Upside: +8.74%
Maintains: Hold
Price Target: $139$150
Current: $154.79
Upside: -3.09%
Maintains: Outperform
Price Target: $30$26
Current: $24.30
Upside: +7.00%
Upgrades: Outperform
Price Target: $39$35
Current: $14.08
Upside: +148.58%
Maintains: Outperform
Price Target: $564$585
Current: $291.45
Upside: +100.72%
Maintains: Market Perform
Price Target: $3$6
Current: $15.05
Upside: -60.13%
Maintains: Outperform
Price Target: $10$8
Current: $7.33
Upside: +9.14%
Upgrades: Outperform
Price Target: $242$329
Current: $284.74
Upside: +15.54%
Upgrades: Market Perform
Price Target: $7$3
Current: $2.16
Upside: +38.89%
Initiates: Market Perform
Price Target: $17
Current: $10.60
Upside: +60.38%
Downgrades: Underweight
Price Target: $28$20
Current: $244.80
Upside: -91.83%
Maintains: Neutral
Price Target: $33$20
Current: $19.88
Upside: +0.60%
Downgrades: Underweight
Price Target: n/a
Current: $3.43
Upside: -